ID: ALA1160424

Max Phase: Preclinical

Molecular Formula: C13H15NO5

Molecular Weight: 265.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H](OC(=O)CNC(=O)Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C13H15NO5/c1-9(13(17)18)19-12(16)8-14-11(15)7-10-5-3-2-4-6-10/h2-6,9H,7-8H2,1H3,(H,14,15)(H,17,18)/t9-/m1/s1

Standard InChI Key:  MVAOZKNWFUOITH-SECBINFHSA-N

Associated Targets(non-human)

Beta-lactamase 730 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.26Molecular Weight (Monoisotopic): 265.0950AlogP: 0.36#Rotatable Bonds: 6
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.46CX Basic pKa: CX LogP: 0.70CX LogD: -2.69
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.72Np Likeness Score: -0.68

References

1. Xu Y, Pratt R.  (1994)  -lactam-recognizing enzymes exhibit different structural specificity in acyclic amide and ester substrates: a starting point in -lactamase evolution?,  (19): [10.1016/0960-894X(94)85027-5]

Source